McKesson (MCK) Reaffirms FY19 Guidance, Preliminary Guidance for Q1 Tops Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Cowen Reiterates Outperform on McKesson (MCK) Following Investor Day
June 29, 2018 7:42 AM EDTCowen reiterated an Outperform rating and $174.00 price target on McKesson (NYSE: MCK) following the company's investor day. Management is focused on driving cost savings and emphasized its increased exposure to growth areas, namely manufacturer services, specialty and retail pharmacy.
MCK fell short of... More
McKesson (MCK) PT Lowered to $158 at RBC Capital, Sees Limited Near to Medium Term Impact from Amazon
June 29, 2018 7:39 AM EDTRBC Capital lowered its price target on McKesson (NYSE: MCK) to $158.00 (from $171.00) while maintaining a Sector Perform rating.
Analyst George Hill notes the company's investor day that was largely overshadowed by the entry of Amazon into the pharma supply... More
Amazon to buy PillPack in potentially disruptive drug retail push
June 28, 2018 8:47 AM EDTBy Ankur Banerjee and Bill Berkrot
(Reuters) - Amazon.com Inc said on Thursday it would buy small online pharmacy PillPack, a move that will put the world's biggest online retailer in direct competition with drugstore chains, drug distributors and pharmacy benefit managers.
The deal's potential to disrupt major players across the drug supply chain nationwide prompted a sell-off in shares of possible rivals, while sending Amazon shares up 2.5 percent.
PillPack supplies pre-sorted prescription drugs and other services to people who take multiple medications, a growing market as the U.S. population ages and requires treatment for... More
